< Zurück zu den aktuellen Neuigkeiten & Events

Neuigkeiten

Patent filings reveal companies embracing microalgae for sustainable foods

November 2020

This week, food giant Unilever announced a €1bn annual sales target for plant-based foods within the next 5-7 years, as part of its “Future Foods” program. This ambitious target is expected to be driven by sales under The Vegetarian Butcher brand, as well as vegan varieties of Ben & Jerry’s, Wall’s, Hellman’s and Magnum.

So, what will be the source of the plant-based fats and proteins needed to support this growth? Vegan Magnums contain pea protein and coconut oil, non-dairy Ben & Jerry’s is made using almond milk, while vegan Cornettos and products in The Vegan Butcher range are based on soy. However, given some of the environmental issues posed by dairy alternatives, such as the high water consumption of almond plants, how sustainable is long-term growth based on these types of proteins?

Unilever is obviously already considering the sustainability of its plant-based offerings, having recently partnered with UK-based algal biotechnology firm Algenuity. The founders of Algenuity have filed an international patent application (published as WO2020/105001) directed to a modified strain of Chlorella vulgaris having a reduced chlorophyll content, and a composition comprising an algae biomass derived from the modified strain. The reduction in chlorophyll is said to overcome the problem of the strong colour, taste and smell normally associated with this microalgal species, making it more suitable for use in foods. Two further applications were filed earlier this year in the UK for modified strains of Chlorella vulgaris.

Microalgae are microscopic, unicellular organisms which convert CO2 into useful nutrients. Given their low carbon footprint and ability to be cultured to a high density, microalgae have gained considerable interest for use in biofuels, cosmetics, pharmaceuticals and as food ingredients, with the global microalgae market estimated to exceed 75 million USD by 2027*.

It is therefore unsurprising that Unilever isn’t the only corporate giant which has recognised the potential of microalgae, and the patent literature reveals other key players taking an interest in the microalgae market. Glaxosmithkline Biologicals has filed a patent application (WO2020/178720), jointly with Washington University, for a nutraceutical composition which may comprise spirulina (microalgae of the Arthospira genus), for improving health and boosting the immune system. Mitsubishi-backed Japanese start-up Tavelmout Corporation is also focussing on mass-produced spirulina as a source of sustainable protein. Like Algenuity, the company seeks to provide foods and beverages which don’t suffer from the characteristic taste and smell of algae, and its pending patent (WO2019/102732) is directed to a culturing process which comprises a decolouration step. Of course, the benefits of microalgae are not limited to foods for human consumption; Mars is seeking patent protection (WO2018/125631) for the use of algal biomass to replace animal plasma as a pet food binder.

As well as an increase in patent filings for microalgae-based products and process in the food tech field, the next few years will likely see more collaborations between big corporates and smaller biotech firms or universities who have specialised knowledge of microalgal strains and culture conditions. This know-how is another valuable source of IP, since the ability to efficiently scale-up microalgae production and incorporate biomass into food compositions while retaining desirable taste and textural properties will be critical to the success of new products. Companies who optimise their IP strategy so as to protect key innovations and strains through patents, while also being able to offer their know-how in collaborations with food giants, will be best placed to capitalize in this growing field.

*Data Bridge Market Research

This article was prepared by HGF Patent Director Dr Jennifer Bailey. If you would like further advice on this or any other matter, please contact Jennifer.  Alternatively, you can contact your usual HGF representative or visit our Contact page to get in touch with your nearest HGF office.

Aktuelle Neuigkeiten

Quinas Technology Wins WIPO Global Award for Innovation in ICT

Our client, Quinas Technology, has been named the winner of the WIPO Global Award 2025 in the ICT Startup category. Quinas is a spin-out from Lancaster University. We have worked …

Weiterlesen

IP Zutaten: Sommer-Rechtsprechungsbericht 2025

Während der Sommer mal mit Sonne, mal mit Wolken aufwartet, lohnt sich ein Blick zurück auf die IP-Entscheidungen der vergangenen Monate. In diesem Rückblick gehen wir auf einige der herausragenden …

Weiterlesen

Prüfungserfolg bei HGF!

Wir freuen uns einmal mehr, Ihnen mitteilen zu können, dass unsere Kolleginnen und Kollegen bei ihren jüngsten Prüfungen erfolgreich waren! Ihr Engagement, ihre Ausdauer und ihr Einsatz für die berufliche …

Weiterlesen

Ist die Ablehnung des Obersten Gerichtshofs im Fall Thatcher ein schwerer Schlag für Doppelgänger?

Der Streit zwischen Thatcher’s Cider Company und Aldi Stores Limited dauert schon lange an und hat im Laufe der Zeit juristische Kontroversen ausgelöst. Am 4. Juni 2025 verweigerte der Oberste …

Weiterlesen

HGF wurde in den IP STARS Patent Rankings 2025 als eine der führenden Patentkanzleien Europas ausgezeichnet

HGF hat erneut einen deutlichen Eindruck in der aktuellen Kanzlei-Rangliste „Managing IP Stars 2025“ hinterlassen und wurde für seine Expertise im Bereich Patentrecht in mehreren Rechtsordnungen mit einer Spitzenplatzierung ausgezeichnet. …

Weiterlesen

Die Große Beschwerdekammer hat heute ihre Entscheidung in der wegweisenden Rechtssache G1/24 veröffentlicht

G1/24, der als einer der wichtigsten Fälle seit Jahrzehnten bezeichnet wird, betrifft die Frage, wie Patentansprüche von den Beschwerdekammern und damit von allen Organen des Europäischen Patentamts auszulegen sind. Die …

Weiterlesen

Die Lokalkammer Hamburg des UPC gibt Leitlinien dazu heraus, inwieweit ein Patent als eigenes „Lexikon“ verwendet werden kann

Agfa NV gegen Gucci & Anors. [UPC_CFI_278/2023] – Lokalkammer Hamburg des UPC (Klepsch, Schilling, Sarlin) – 30. April 2025 Während wir auf eine Entscheidung der Großen Beschwerdekammer des EPA in …

Weiterlesen

MevoCem von CIPA für den Earthshot Prize nominiert

Wir freuen uns, Ihnen mitteilen zu können, dass unser Mandant Material Evolution vom Chartered Institute of Patent Attorneys (CIPA) für den weltweit renommierten Earthshot Prize nominiert wurde, in Anerkennung seiner …

Weiterlesen